Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the EADV 2024 Congress ...

The funding will enable the company in conducting Phase II human clinical trials for its potential drug candidate for ...

Ahammune Biosciences, a clinical-stage therapeutics company focused on developing new treatments for skin diseases, has ...

Biotech startup Ahammune Biosciences has raised $5 million in Series A funding round led by pi Ventures. The round also ...

The biotech startup will use the funds to assist its Phase II human clinical trials for its drug candidate for vitiligo.

Biotech startup Ahammune Biosciences has raised $5 Mn (about INR 41 Cr) in its Series A round led by pi Ventures.

China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on September ...

Vitiligo is a skin condition that’s little understood and it often takes a long time to diagnose, but now a new treatment could help to cure it. It currently affects around 70 million people around ...

In addition to vitiligo, Mini also works with cancer survivors, helping to reconstruct areolas post-mastectomy, and individuals with burn scars or surgical marks. Her approach is deeply personal, ...

Aesthetic procedures like permanent makeup are usually deemed as “kaartehan” (vanity), but according to Kristine Lucas, a ...